HR and cancer: Patients had a mean age of 63.1 years, 8% (n = 151) were premenopausal, 17% (n = 337) had a known family history of BRCA1/2-related cancer, 88% (n = 1703) had HR+/HER2− disease, and 12% (n = 223) had TNBC.